Advancing Preoperative Strategies for Thyroidectomy in Graves' Disease: A Narrative Review
- PMID: 38046703
- PMCID: PMC10693191
- DOI: 10.7759/cureus.48156
Advancing Preoperative Strategies for Thyroidectomy in Graves' Disease: A Narrative Review
Abstract
Graves' disease is an autoimmune disorder characterized by thyroid-stimulating antibodies that can potentially lead to thyrotoxicosis, goiter, skin disease, and eye disease. Available treatment options for Graves' disease include management with antithyroid drugs (ATDs), thyroid ablation with radioactive iodine (RAI), and surgical thyroid gland removal. For individuals unable to reach a normal thyroid hormone level, promptly considering a thyroidectomy is essential. Preoperative strategies to achieve a euthyroid state prevent thyroid storms and minimize postoperative complications and are therefore crucial. While variations in professional guidance exist, this review focuses on standard medical interventions as well as compares respective guidelines set forth by the American Thyroid Association, the European Thyroid Association, the American Association of Clinical Endocrinology, and the American Association of Endocrine Surgeons. There is consensus among these organizations underscoring the importance of rendering patients euthyroid prior to surgery and the use of ATDs. Most guidelines recommend screening for vitamin D deficiency as well as endorse thyroidectomy as the preferred treatment option for hyperthyroidism with skilled surgeons. Nevertheless, discrepancies do become apparent in aspects such as potassium iodide (SSKI) course duration and preoperative dexamethasone administration. By understanding these differing approaches, healthcare professionals can more effectively manage Graves' disease prior to surgery, resulting in improved patient outcomes and enhanced surgical success.
Keywords: antithyroid agents; goiter; graves´disease; thyroid crisis; thyrotoxicosis.
Copyright © 2023, Elkhoury et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures


References
-
- Incidence rate and clinical features of hyperthyroidism in a long-term iodine sufficient area of Sweden (Gothenburg) 2003-2005. Nyström HF, Jansson S, Berg G. Clin Endocrinol (Oxf) 2013;78:768–776. - PubMed
-
- Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Bahn Chair RS, Burch HB, Cooper DS, et al. Thyroid. 2011;21:593–646. - PubMed
-
- A 2013 European survey of clinical practice patterns in the management of Graves' disease. Bartalena L, Burch HB, Burman KD, Kahaly GJ. Clin Endocrinol (Oxf) 2016;84:115–120. - PubMed
Publication types
LinkOut - more resources
Full Text Sources